Quarterly report pursuant to Section 13 or 15(d)

CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)

v3.21.2
CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
Total
Subordinate Voting Shares
Super Voting Shares
Share Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2019   32,844,000 203,000    
Balance, amount at Dec. 31, 2019 $ 23,686,000     $ 96,160,000 $ (72,474,000)
Net loss (17,802,000) $ 0 $ 0 0 (17,802,000)
Shares issued in connection with convertible debenture offering, shares   250,000      
Shares issued in connection with convertible debenture offering, amount 62,000     62,000 0
Shares issued in connection with conversion of convertible debentures, shares   54,000      
Shares issued in connection with conversion of convertible debentures, amount 11,000     11,000 0
Issuance of shares associated with acquisitions, amount 77,000       0
Issuance of stock warrants, amount 1,556,000       0
Exercise of warrants, shares   106,000      
Exercise of warrants, amount 30,000       0
Share-based compensation expense, shares   248,000      
Share-based compensation expense, amount 2,012,000       0
Balance, shares at Sep. 30, 2020   33,502,000 203,000    
Balance, amount at Sep. 30, 2020 9,632,000       (90,276,000)
Balance, shares at Jun. 30, 2020   33,342,000 203,000    
Balance, amount at Jun. 30, 2020 10,498,000     99,603,000 (89,105,000)
Net loss (1,171,000) $ 0 $ 0 0 (1,171,000)
Shares issued in connection with convertible debenture offering, shares   250,000      
Shares issued in connection with convertible debenture offering, amount 62,000     62,000 0
Shares issued in connection with conversion of convertible debentures, shares   54,000      
Shares issued in connection with conversion of convertible debentures, amount 11,000     11,000 0
Issuance of shares associated with acquisitions, amount 77,000     77,000 0
Issuance of stock warrants, amount 1,556,000       0
Exercise of warrants, shares   106,000      
Exercise of warrants, amount 30,000       0
Share-based compensation expense, shares   248,000      
Share-based compensation expense, amount 187,000       0
Balance, shares at Sep. 30, 2020   33,502,000 203,000    
Balance, amount at Sep. 30, 2020 9,632,000       (90,276,000)
Balance, shares at Dec. 31, 2020   57,617,000 203,000    
Balance, amount at Dec. 31, 2020 31,156,000     125,540,000 (94,384,000)
Net loss (14,685,000) $ 0 $ 0 0 (14,685,000)
Shares issued in connection with conversion of convertible debentures, shares   2,580,000      
Shares issued in connection with conversion of convertible debentures, amount 514,000     514,000 0
Issuance of shares associated with acquisitions, amount 43,259,000     43,259,000 0
Exercise of warrants, shares   1,511,000      
Exercise of warrants, amount 718,000       0
Share-based compensation expense, shares   460,000      
Share-based compensation expense, amount 986,000       0
Issuance of shares associated with acquisitions, shares   30,641,000      
Issuance of shares associated with subordinate voting share offering, shares   18,000,000      
Issuance of shares associated with subordinate voting share offering, amount $ 17,970,000       0
Exercise of options, shares 0 78,000      
Exercise of options, amount $ 48,000       0
Balance, shares at Sep. 30, 2021   110,887,000 203,000    
Balance, amount at Sep. 30, 2021 79,966,000       (109,069,000)
Balance, shares at Jun. 30, 2021   92,423,000 203,000    
Balance, amount at Jun. 30, 2021 70,244,000     170,613,000 (100,369,000)
Net loss (8,700,000) $ 0 $ 0 0 (8,700,000)
Shares issued in connection with conversion of convertible debentures, shares   187,000      
Shares issued in connection with conversion of convertible debentures, amount 37,000     37,000 0
Exercise of warrants, shares   186,000      
Exercise of warrants, amount 52,000       0
Share-based compensation expense, shares   89,000      
Share-based compensation expense, amount 361,000       0
Issuance of shares associated with subordinate voting share offering, shares   18,000,000      
Issuance of shares associated with subordinate voting share offering, amount 17,970,000     $ 17,970,000 0
Exercise of options, shares   2,000      
Exercise of options, amount 2,000       0
Balance, shares at Sep. 30, 2021   110,887,000 203,000    
Balance, amount at Sep. 30, 2021 $ 79,966,000       $ (109,069,000)